Trial intelligence / Profile preview

Linzagolix Phase 2 in Endometriosis

NCT01533532Phase 2Completed

Sponsor
Kissei Pharmaceutical Co., Ltd.
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.

02

Drugs

linzagolix
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT01533532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01533532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call